Global Regulatory Intelligence
Log in |  Register

Login to your account

Username *
Password *
Remember Me

Create an account

Registering to our Regulatory Updates easy andis should only
take few minutes. To begin, enter your email enter your email
address below so we can check to see if it is already existing
in our records. Your email address will also be used as your
user name when you log in.

Fields marked with an asterisk (*) are required.
Name *
Username *
Password *
Verify password *
Email *
Verify email *
Captcha *
Reload Captcha

Belgium: FAMHP Amended Guidelines on Labelling and Packaging for Medicines for Human Use

Tuesday, February 01, 2018: The Federal Agency for Medicines and Health Products (FAMHP) of Belgium has updated guidelines on labelling and packaging for medicines for human use. Market authorisation holders for medicines for human use must follow certain labelling and packaging guidelines.

The applicable ‘labelling of medicines’ guidelines within the context of a new market authorisation (MA), renewal or variation of medicines for human use have been amended. The guidelines have been amended to meet European guidelines and other national or international agreements.

The main changes are:

  • section 16, 17, 18 and 19 of the packaging text according to the QRD template;
  • definition of small packages;
  • definition and submission of mock-ups;
  • use of trademarks, symbols ® and TM or statement of ‘trademark of’;
  • use of logos and use of QR codes;
  • labelling of combination packaging and labelling of homeopathic medicines.
More Details
© 2016 MakroCare. All Rights Reserved.
  Privacy policy